# DAY33 Quality Self-Audit

| Dimension | Score / 5 | Evidence |
|---|---:|---|
| Roadmap fidelity | 5 | Implements all DAY33 mandatory outputs and independent-roadmap claim boundary. |
| DAY32 contract inheritance | 5 | Exact evidence tier semantics and WindowIdentity context preserved. |
| Dataset governance | 5 | Four primary-source license/provenance-verified sources; ambiguous/restricted sources deferred. |
| Provenance | 5 | Version/DOI/source metadata, synthetic source hashes and transform chains recorded. |
| Reproducibility | 5 | Deterministic double-build test and content hashes pass. |
| Leakage control | 5 | Development/locked seed separation and hidden locked truth commitments. |
| Safety / clinical claims | 5 | Synthetic/public evidence explicitly non-clinical; pathology fabrication rejected. |
| Data minimization | 5 | No public raw payload, patient data or direct identifiers in package. |
| Window identity | 5 | Every corpus payload item uses DAY22 QC_WINDOW_WITH_CONTEXT. |
| Test depth | 5 | 64 focused + 242 overlay regression PASS. |
| Failure safety | 5 | Invalid license, hash, partition, identifier and pathology conditions fail closed. |
| Documentation | 5 | Execution Plan >4k words; Feynman Guide >4k words. |
| Integration hygiene | 5 | Additive repo patch; upstream contracts not overwritten. |
| ML governance | 5 | No model fitting/training/threshold tuning in DAY33. |
| Portfolio transparency | 5 | Public-source verified vs raw-not-acquired and clinical-not-validated states explicit. |

**Overall:** PASS — engineering complete with peer review still pending.
